<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Psychopharmacol Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin Psychopharmacol Neurosci</journal-id>
      <journal-title-group>
        <journal-title>Clinical Psychopharmacology and Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1738-1088</issn>
      <issn pub-type="epub">2093-4327</issn>
      <publisher>
        <publisher-name>Korean College of Neuropsychopharmacology</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27489389</article-id>
      <article-id pub-id-type="pmc">4977809</article-id>
      <article-id pub-id-type="doi">10.9758/cpn.2016.14.3.314</article-id>
      <article-id pub-id-type="publisher-id">cpn-14-314</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Manic Symptoms Due to Methylphenidate Use in an Adolescent with Traumatic Brain Injury</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ekinci</surname>
            <given-names>Ozalp</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cpn-14-314">1</xref>
          <xref ref-type="corresp" rid="c1-cpn-14-314"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Direk</surname>
            <given-names>Meltem &#xC7;obano&#x11F;ullari</given-names>
          </name>
          <xref ref-type="aff" rid="af2-cpn-14-314">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ekinci</surname>
            <given-names>Nuran</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cpn-14-314">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okuyaz</surname>
            <given-names>Cetin</given-names>
          </name>
          <xref ref-type="aff" rid="af2-cpn-14-314">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-cpn-14-314"><label>1</label>Department of Child and Adolescent Psychiatry, Mersin University Medical Faculty, Mersin, 
<country>Turkey</country></aff>
      <aff id="af2-cpn-14-314"><label>2</label>Department of Pediatric Neurology, Mersin University Medical Faculty, Mersin, 
<country>Turkey</country></aff>
      <author-notes>
        <corresp id="c1-cpn-14-314">Address for correspondence: Ozalp Ekinci, Department of Child and Adolescent Psychiatry, Mersin University School of Medicine, No:31, &#xC7;iftlikk&#xF6;y, Vali &#x15E;enol Engin Cd., 33110 Mersin, Turkey, Tel: +90-506-611-15-00, Fax: +90-3242410092, E-mail: <email>ozalpekinci@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <volume>14</volume>
      <issue>3</issue>
      <fpage>314</fpage>
      <lpage>317</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>03</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016, Korean College of Neuropsychopharmacology</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access">
          <license-p>This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Almost one-fifth of children who sustain a traumatic brain injury (TBI) are under the risk of attention problems after injury. The efficacy and tolerability of methylphenidate (MPH) in children with a history of TBI have not been completely identified. In this case report, MPH-induced manic symptoms in an adolescent with TBI will be summarized. A male patient aged 17 years was admitted with the complaints of attention difficulties on schoolwork and forgetfullness which became evident after TBI. Long-acting MPH was administered with the dose of 18 mg/day for attention problems. After one week, patient presented with the complaints of talking to himself, delusional thoughts, irritability and sleeplessness. This case highlights the fact that therapeutic dose of MPH may cause mania-like symptoms in children with TBI. Close monitarization and slow dose titration are crucial when considering MPH in children with TBI.</p>
      </abstract>
      <kwd-group>
        <kwd>Brain injuries</kwd>
        <kwd>Adolescent</kwd>
        <kwd>Methylphenidate</kwd>
        <kwd>Bipolar disorder</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in children, resulting in numerous physical, behavioral and cognitive deficits.<xref rid="b1-cpn-14-314" ref-type="bibr">1)</xref> Cognitive deficits may involve problems with attention, memory and executive functions that worsen with increasing TBI severity.<xref rid="b2-cpn-14-314" ref-type="bibr">2</xref>&#x2013;<xref rid="b4-cpn-14-314" ref-type="bibr">4)</xref> Attention deficit hyperactivity disorder (ADHD) that develops after injury without evidence of preinjury ADHD is often referred to as secondary ADHD.<xref rid="b5-cpn-14-314" ref-type="bibr">5)</xref></p>
      <p>Methylphenidate (MPH), a well-accepted treatment for ADHD, may be associated with behavioral adverse effects.<xref rid="b6-cpn-14-314" ref-type="bibr">6)</xref> Amongst these reactions, psychotic symptoms are the most terrifiying ones for families. Although firstly reported in the early 1970s, the terminology of psychotic symptoms due to MPH use has not been well described. The first report of stimulant-induced psychosis and/or mania symptoms in children included three cases and used the definition of &#x2018;methylphenidate hallucinosis&#x2019;.<xref rid="b7-cpn-14-314" ref-type="bibr">7)</xref> In these cases, hallucinations were the prominent presenting symptoms. In later reports, the term &#x2018;toxicosis&#x2019; has been used to distinguish transient psychotic symptoms associated with stimulant use.<xref rid="b8-cpn-14-314" ref-type="bibr">8)</xref> Toxicosis term specifically indicates that the psychotic-like or mania-like symptoms resolve following discontinuation of stimulant. When the adverse reaction symptoms continue or recur after discontinuation, a rediagnosis of bipolar disorder or schizophrenia may be considered.<xref rid="b8-cpn-14-314" ref-type="bibr">8)</xref></p>
      <p>The efficacy and tolerability of stimulants in children with a history of TBI have not been completely identified. In this case report, the emergence of manic symptoms with MPH use in an adolescent with TBI will be summarized. Informed consent was obtained from the patient&#x2019;s parents.</p>
    </sec>
    <sec>
      <title>CASE</title>
      <p>A male patient aged 17 years was admitted to the child and adolescent psychiatry clinic with the complaints of attention difficulties on schoolwork and forgetfullness. Patient&#x2019;s medical history revealed that he had a car accident 3 months ago which included a TBI. Upon admission to emergency room, his Glasgow Coma Scale score was 6/15. At the time of the accident, his neurologic assessment was marked with upper and lower muscular weakness, memory deficits and frank mutism. This clinic picture resolved in 2 months; however, he has been speaking slowly since then. Before the accident, he was reported to have a succesfull academic life in both elementary and secondary school. He never had attention problems, hyperactivity or impulsivity. Prior psychiatric history of the patient did not reveal any psychiatric disorder diagnosis. There was no known history of psychiatric disorders in both parents and extended family members. After the accident, he had difficulty on sustaining attention on school work and forgetfulness on daily duties. He described himself as &#x201C;I study hard and try to do my best but I am far from my previous academic performance. I can&#x2019;t focus, can&#x2019;t sustain my attention and I do simple mistakes&#x201D;. Deficits in cerebellar tests, slow speech and difficulty at walking on hills were evident in his neuorologic examination. His magnetic resonance imaging (MRI), which was performed 10 days after the injury, revealed postinjury findings on the right frontal lob, lef temporal lobe and corpus callosum (<xref rid="f1-cpn-14-314" ref-type="fig">Fig. 1</xref>). Sleep and awake electroencephalography (EEG) of the patient was also obtained on the 7th day after injury. Sleep EEG showed 4&#x2013;6 Hz theta waves mixed with V waves and sleep spindles. Awake EEG showed 8&#x2013;9 Hz alpha waves in posterior regions. There were no cerebral assymetry, focal slowing or epileptiform discharges.</p>
      <p>A diagnosis of major neurocognitive disorder due to TBI was made and osmotic release oral system (OROS) MPH was administered with the dose of 18 mg/day for attention problems. After one week, patient was admitted to the clinic with the complaints of talking to himself, delusional thoughts, irritability and sleeplessness. He was reported to speak everyone that he and his father were prophets. He was reported to be more talkative than usual especially in social situations. His psychiatric interview revealed elevated mood, incongruent affect and delusional thoughts about his mission to save the world. The patient&#x2019;s Young Mania Rating Scale (YMRS) score was 29. His general pediatric and neurologic evaluation did not reveal any additional findings. The Naranjo adverse drug reaction probability scale score was 8. With the suspect of a medication induced adverse reaction, MPH was discontinued and all of the symptoms resolved in 3 days. Three days after the discontinuation of MPH, YMRS score decreased to 4.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Almost one fifth of children who sustain a TBI are under the risk of attention problems after injury.<xref rid="b9-cpn-14-314" ref-type="bibr">9)</xref> Children with severe TBI are shown to have a greater risk for developing postinjury attention problems.<xref rid="b10-cpn-14-314" ref-type="bibr">10)</xref> The consequences of attention problems may extend beyond school functioning and can have negative impacts on a child&#x2019;s social relationships, emotional well-being, self esteem and quality of life.<xref rid="b11-cpn-14-314" ref-type="bibr">11)</xref></p>
      <p>Despite the high burden of attention problems in children and adolescents after TBI, only a limited number of controlled studies, all with small sample size and short duration, have been conducted to date. In an early study by Williams <italic>et al</italic>.,<xref rid="b12-cpn-14-314" ref-type="bibr">12)</xref> no signifficant effect of MPH was reported in 10 children with mild-to-severe head trauma. Mahalick <italic>et al</italic>.<xref rid="b13-cpn-14-314" ref-type="bibr">13)</xref> studied 14 children with TBIs of varying severity and MPH treatment resulted in significantly greater scores on the study measures of attention when compared with placebo. A chart review on 10 children with TBI has also shown positive findings on attention and behavior.<xref rid="b14-cpn-14-314" ref-type="bibr">14)</xref> A recent placebo controlled study, in which only five children with TBI have completed the study procedures, reported a small but significant effect on attention and hyperactivity with psychostimulants.<xref rid="b1-cpn-14-314" ref-type="bibr">1)</xref> Of note, none of the mentioned studies focused on the possible adverse effects of MPH and treatment associated mania or psychosis was not reported.</p>
      <p>The risk of stimulant-induced psychosis and/or mania symptoms in children as estimated as 1 in 400.<xref rid="b8-cpn-14-314" ref-type="bibr">8)</xref> In a significant proportion of cases, toxicosis symptoms develop at the theraupatic doses of stimulants.<xref rid="b15-cpn-14-314" ref-type="bibr">15)</xref> Presenting symptoms usually emerge shorty after the start of the treatment or with a dose increase. In the great majority of such reports, behavioral symptoms resolve within a week after discontinuation.<xref rid="b16-cpn-14-314" ref-type="bibr">16)</xref> In accordance with the literature, manic symptoms started within the first week of MPH treatment, and rapidly subsided with discontinuation in our case. It has been shown that stimulant induced toxicosis symptoms are highly similar to those of bipolar disorder or schizophrenia.<xref rid="b8-cpn-14-314" ref-type="bibr">8)</xref> Symptoms may include euphoria, grandiosity, paranoid delusions, confusion and auditory hallucinations.<xref rid="b8-cpn-14-314" ref-type="bibr">8</xref>,<xref rid="b16-cpn-14-314" ref-type="bibr">16)</xref> Bizarre behaviors, hallucinations involving visual and/or tactile sensations of insects, snakes, or worms were also reported, especially in younger children.<xref rid="b17-cpn-14-314" ref-type="bibr">17)</xref> Our case also presented with grandiose delusions with religious content and socialy disinhibited behaviors which are commonly reported in manic episodes. In the differential diagnosis, bipolar disorder manic episode might be a possibility. However, the short duration of symptoms and the direct relationship with MPH use do not fit the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-V) criteria.<xref rid="b18-cpn-14-314" ref-type="bibr">18)</xref> Moroever, MPH-induced mania symptoms must be considered as a different clinical entity than the highly hereditery bipolar disorder. Acute onset of clinical picture, absence of mood symptoms in the prior psychiatric history and the lack of the family history in the present case are against a bipolar disorder diagnosis.<xref rid="b17-cpn-14-314" ref-type="bibr">17)</xref> In light of the available research and the suggested terminology, toxicosis term appears to be the best description of the case.</p>
      <p>Although not completely identified, the emergence of psychotic symptoms may be related with the mechanism of action of MPH. MPH mainly works via the reuptake inhibition of dopamine, and less prominently noradrenaline, in the striatal regions. Effects on selected frontal and temporal regions were also observed with MPH use.<xref rid="b19-cpn-14-314" ref-type="bibr">19)</xref> Increased dopaminergic and/or noraderengic transmission with MPH, especially in higher doses, may be associated with psychotic/manic symptoms.<xref rid="b8-cpn-14-314" ref-type="bibr">8)</xref> Although stimulant-induced toxicosis appears to be an idiosyncratic reaction, some risk factors have been proposed. The use of high doses, premorbid ADHD symptoms and mental retardation were suggested to be related with an increased risk.<xref rid="b20-cpn-14-314" ref-type="bibr">20)</xref></p>
      <p>In the present case, the disrupted brain regions, as shown by the MRI findings, might give rise to a vulnerability for this behavioral adverse reaction. Right frontal, left temporal regions and corpus callosum, which were injuried in our case, are among the shown regions for the neurobiology of bipolar disorder in children and adolescents.<xref rid="b21-cpn-14-314" ref-type="bibr">21</xref>,<xref rid="b22-cpn-14-314" ref-type="bibr">22)</xref> Deficits in executive functions, visual-motor responses and working memory were reported in children with traumatic lesions on corpus callosum.<xref rid="b23-cpn-14-314" ref-type="bibr">23)</xref> The previous literature on mania symptoms after TBI is limited. Some studies have shown that multifocal lesions, mainly in temporal poles, are associated with mania.<xref rid="b24-cpn-14-314" ref-type="bibr">24)</xref> Both left and right temporal lesions were found to be linked with mania symptoms.<xref rid="b25-cpn-14-314" ref-type="bibr">25</xref>,<xref rid="b26-cpn-14-314" ref-type="bibr">26)</xref> A previous review on 66 adult TBI patients have shown the incidence of mania as 9% within 12 months of follow-up.<xref rid="b27-cpn-14-314" ref-type="bibr">27)</xref> There is evidence that severe TBI and male gender are associated with an increased risk of mania.<xref rid="b28-cpn-14-314" ref-type="bibr">28</xref>,<xref rid="b29-cpn-14-314" ref-type="bibr">29)</xref> The relationship between age and mania has not been specifically documented, however, younger age has been found as a risk factor for psychiatric disorders after TBI.<xref rid="b30-cpn-14-314" ref-type="bibr">30</xref>,<xref rid="b31-cpn-14-314" ref-type="bibr">31)</xref> In our case, diffuse disruptions in fronto-temporal grey matter might have resulted with an increased vulnerability to manic symptoms. Since these vulnerable regions are also among the shown target regions of MPH, an additive effect of MPH might have occured. In other words, MPH use might have led to either irreguler or overt activity in the brain regions which were already disrupted with the head trauma. Eventually, the additive effects of head trauma and MPH use might have resulted in the emergence of manic symptoms in our case, which did not have any premorbid psychiatric history.</p>
      <p>This case highlights the fact that therapeutic dose of MPH may cause mania-like symptoms in children with TBI. Close monitarization and slow dose titration are crucial when considering MPH in children with TBI.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1-cpn-14-314">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nikles</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>McKinlay</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Carmont</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Senior</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Waugh</surname>
              <given-names>MC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury--a pilot study</article-title>
          <source>Trials</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>54</fpage>
          <pub-id pub-id-type="doi">10.1186/1745-6215-15-54</pub-id>
          <!--<pub-id pub-id-type="pmcid">3925439</pub-id>-->
          <pub-id pub-id-type="pmid">24524676</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-cpn-14-314">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Catroppa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Traumatic brain injury in childhood: rehabilitation considerations</article-title>
          <source>Dev Neurorehabil</source>
          <year>2009</year>
          <volume>12</volume>
          <fpage>53</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1080/17518420802634476</pub-id>
          <pub-id pub-id-type="pmid">19253095</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-cpn-14-314">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beauchamp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Catroppa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Godfrey</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Morse</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rosenfeld</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Selective changes in executive functioning ten years after severe childhood traumatic brain injury</article-title>
          <source>Dev Neuropsychol</source>
          <year>2011</year>
          <volume>36</volume>
          <fpage>578</fpage>
          <lpage>595</lpage>
          <pub-id pub-id-type="doi">10.1080/87565641.2011.555572</pub-id>
          <pub-id pub-id-type="pmid">21667362</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-cpn-14-314">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Swartwout</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Yeates</surname>
              <given-names>KO</given-names>
            </name>
            <name>
              <surname>Walz</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Stancin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wade</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Traumatic brain injury in young children: postacute effects on cognitive and school readiness skills</article-title>
          <source>J Int Neuropsychol Soc</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>734</fpage>
          <lpage>745</lpage>
          <pub-id pub-id-type="doi">10.1017/S1355617708081150</pub-id>
          <!--<pub-id pub-id-type="pmcid">2733858</pub-id>-->
          <pub-id pub-id-type="pmid">18764969</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-cpn-14-314">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerring</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Brady</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vasa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Grados</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bandeen-Roche</surname>
              <given-names>KJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury</article-title>
          <source>J Am Acad Child Adolesc Psychiatry</source>
          <year>1998</year>
          <volume>37</volume>
          <fpage>647</fpage>
          <lpage>654</lpage>
          <pub-id pub-id-type="doi">10.1097/00004583-199806000-00015</pub-id>
          <pub-id pub-id-type="pmid">9628085</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-cpn-14-314">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YN</given-names>
            </name>
            <name>
              <surname>Cheong</surname>
              <given-names>US</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>MS</given-names>
            </name>
            <etal/>
          </person-group>
          <collab>Korean OROS-MPH Study Group</collab>
          <article-title>Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A multi-center, open-label study in Korea</article-title>
          <source>Clin Psychopharmacol Neurosci</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>29</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="doi">10.9758/cpn.2011.9.1.29</pub-id>
          <!--<pub-id pub-id-type="pmcid">3568652</pub-id>-->
          <pub-id pub-id-type="pmid">23430964</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-cpn-14-314">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lucas</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Methylphenidate hallucinosis</article-title>
          <source>JAMA</source>
          <year>1971</year>
          <volume>217</volume>
          <fpage>1079</fpage>
          <lpage>1081</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.1971.03190080041008</pub-id>
          <pub-id pub-id-type="pmid">5109429</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-cpn-14-314">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder</article-title>
          <source>Am J Psychiatry</source>
          <year>2006</year>
          <volume>163</volume>
          <fpage>1149</fpage>
          <lpage>1152</lpage>
          <pub-id pub-id-type="doi">10.1176/ajp.2006.163.7.1149</pub-id>
          <pub-id pub-id-type="pmid">16816217</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-cpn-14-314">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Backeljauw</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kurowski</surname>
              <given-names>BG</given-names>
            </name>
          </person-group>
          <article-title>Interventions for attention problems after pediatric traumatic brain injury: what is the evidence?</article-title>
          <source>PM R</source>
          <year>2014</year>
          <volume>6</volume>
          <fpage>814</fpage>
          <lpage>824</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pmrj.2014.04.004</pub-id>
          <!--<pub-id pub-id-type="pmcid">4177354</pub-id>-->
          <pub-id pub-id-type="pmid">24755513</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-cpn-14-314">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Max</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lansing</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Koele</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Castillo</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Bokura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schachar</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Attention deficit hyperactivity disorder in children and adolescents following traumatic brain injury</article-title>
          <source>Dev Neuropsychol</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>159</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="doi">10.1080/87565641.2004.9651926</pub-id>
          <pub-id pub-id-type="pmid">14984333</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-cpn-14-314">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wehmeier</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Schacht</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barkley</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life</article-title>
          <source>J Adolesc Health</source>
          <year>2010</year>
          <volume>46</volume>
          <fpage>209</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jadohealth.2009.09.009</pub-id>
          <pub-id pub-id-type="pmid">20159496</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-cpn-14-314">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Ris</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Ayyangar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schefft</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Berch</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Recovery in pediatric brain injury: is psychostimulant medication beneficial?</article-title>
          <source>J Head Trauma Rehabil</source>
          <year>1998</year>
          <volume>13</volume>
          <fpage>73</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1097/00001199-199806000-00007</pub-id>
          <pub-id pub-id-type="pmid">9582180</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-cpn-14-314">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahalick</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Carmel</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Molofsky</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Heary</surname>
              <given-names>RF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Psychopharmacologic treatment of acquired attention disorders in children with brain injury</article-title>
          <source>Pediatr Neurosurg</source>
          <year>1998</year>
          <volume>29</volume>
          <fpage>121</fpage>
          <lpage>126</lpage>
          <pub-id pub-id-type="doi">10.1159/000028705</pub-id>
          <pub-id pub-id-type="pmid">9838263</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-cpn-14-314">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hornyak</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Hurvitz</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>The use of methylphenidate in paediatric traumatic brain injury</article-title>
          <source>Pediatr Rehabil</source>
          <year>1997</year>
          <volume>1</volume>
          <fpage>15</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="doi">10.3109/17518429709060937</pub-id>
          <pub-id pub-id-type="pmid">9689233</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-cpn-14-314">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hellander</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Medication-induced mania: ethical issues and the need for more research</article-title>
          <source>J Child Adolesc Psychopharmacol</source>
          <year>2003</year>
          <volume>13</volume>
          <fpage>199</fpage>
          <pub-id pub-id-type="doi">10.1089/104454603322163916</pub-id>
          <pub-id pub-id-type="pmid">12880513</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-cpn-14-314">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shibib</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chalhoub</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Stimulant induced psychosis</article-title>
          <source>Child Adolesc Ment Health</source>
          <year>2009</year>
          <volume>14</volume>
          <fpage>20</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1475-3588.2008.00490.x</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-cpn-14-314">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mosholder</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Gelperin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hammad</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Phelan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Johann-Liang</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children</article-title>
          <source>Pediatrics</source>
          <year>2009</year>
          <volume>123</volume>
          <fpage>611</fpage>
          <lpage>616</lpage>
          <pub-id pub-id-type="doi">10.1542/peds.2008-0185</pub-id>
          <pub-id pub-id-type="pmid">19171629</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-cpn-14-314">
        <label>18</label>
        <element-citation publication-type="book">
          <collab>American Psychiatric Association</collab>
          <source>Diagnostic and statistical manual of mental disorders</source>
          <edition>5th ed</edition>
          <publisher-loc>Washington, DC</publisher-loc>
          <publisher-name>American Psychiatric Association</publisher-name>
          <year>2013</year>
        </element-citation>
      </ref>
      <ref id="b19-cpn-14-314">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Czerniak</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sikoglu</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Mick</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Frazier</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review</article-title>
          <source>Harv Rev Psychiatry</source>
          <year>2013</year>
          <volume>21</volume>
          <fpage>151</fpage>
          <lpage>162</lpage>
          <!--<pub-id pub-id-type="pmcid">4103657</pub-id>-->
          <pub-id pub-id-type="pmid">23660970</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-cpn-14-314">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chakraborty</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Grover</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Methylphenidate-induced mania-like symptoms</article-title>
          <source>Indian J Pharmacol</source>
          <year>2011</year>
          <volume>43</volume>
          <fpage>80</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.4103/0253-7613.75678</pub-id>
          <!--<pub-id pub-id-type="pmcid">3062130</pub-id>-->
          <pub-id pub-id-type="pmid">21455430</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-cpn-14-314">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demeter</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Townsend</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Findling</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Current research in child and adolescent bipolar disorder</article-title>
          <source>Dialogues Clin Neurosci</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>215</fpage>
          <lpage>228</lpage>
          <!--<pub-id pub-id-type="pmcid">3181873</pub-id>-->
          <pub-id pub-id-type="pmid">18689291</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-cpn-14-314">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnea-Goraly</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Karchemskiy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Howe</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Reiss</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Limbic and corpus callosum aberrations in adolescents with bipolar disorder: a tract-based spatial statistics analysis</article-title>
          <source>Biol Psychiatry</source>
          <year>2009</year>
          <volume>66</volume>
          <fpage>238</fpage>
          <lpage>244</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.02.025</pub-id>
          <pub-id pub-id-type="pmid">19389661</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-cpn-14-314">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Treble</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hasan</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Iftikhar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stuebing</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Kramer</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>CS</given-names>
              <suffix>Jr</suffix>
            </name>
            <etal/>
          </person-group>
          <article-title>Working memory and corpus callosum microstructural integrity after pediatric traumatic brain injury: a diffusion tensor tractography study</article-title>
          <source>J Neurotrauma</source>
          <year>2013</year>
          <volume>30</volume>
          <fpage>1609</fpage>
          <lpage>1619</lpage>
          <pub-id pub-id-type="doi">10.1089/neu.2013.2934</pub-id>
          <!--<pub-id pub-id-type="pmcid">3787334</pub-id>-->
          <pub-id pub-id-type="pmid">23627735</pub-id>
        </element-citation>
      </ref>
      <ref id="b24-cpn-14-314">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwarzbold</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Rufino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Amante</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Thais</surname>
              <given-names>ME</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Psychiatric disorders and traumatic brain injury</article-title>
          <source>Neuropsychiatr Dis Treat</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>797</fpage>
          <lpage>816</lpage>
          <!--<pub-id pub-id-type="pmcid">2536546</pub-id>-->
          <pub-id pub-id-type="pmid">19043523</pub-id>
        </element-citation>
      </ref>
      <ref id="b25-cpn-14-314">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Rapid cycling bipolar disorder after left temporal polar damage</article-title>
          <source>Brain Inj</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>355</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="doi">10.1080/0269905031000070170</pub-id>
          <pub-id pub-id-type="pmid">12637187</pub-id>
        </element-citation>
      </ref>
      <ref id="b26-cpn-14-314">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Boston</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Starkstein</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <article-title>Comparison of mania and depression after brain injury: causal factors</article-title>
          <source>Am J Psychiatry</source>
          <year>1988</year>
          <volume>145</volume>
          <fpage>172</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="doi">10.1176/ajp.145.2.172</pub-id>
          <pub-id pub-id-type="pmid">3341462</pub-id>
        </element-citation>
      </ref>
      <ref id="b27-cpn-14-314">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jorge</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Starkstein</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Arndt</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Forrester</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Geisler</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
          <article-title>Secondary mania following traumatic brain injury</article-title>
          <source>Am J Psychiatry</source>
          <year>1993</year>
          <volume>150</volume>
          <fpage>916</fpage>
          <lpage>921</lpage>
          <pub-id pub-id-type="doi">10.1176/ajp.150.6.916</pub-id>
          <pub-id pub-id-type="pmid">8494069</pub-id>
        </element-citation>
      </ref>
      <ref id="b28-cpn-14-314">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shukla</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Godwin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Mania following head trauma</article-title>
          <source>Am J Psychiatry</source>
          <year>1987</year>
          <volume>144</volume>
          <fpage>93</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1176/ajp.144.1.93</pub-id>
          <pub-id pub-id-type="pmid">3799847</pub-id>
        </element-citation>
      </ref>
      <ref id="b29-cpn-14-314">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Reekum</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bolago</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Finlayson</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Garner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Links</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
          <article-title>Psychiatric disorders after traumatic brain injury</article-title>
          <source>Brain Inj</source>
          <year>1996</year>
          <volume>10</volume>
          <fpage>319</fpage>
          <lpage>327</lpage>
          <pub-id pub-id-type="doi">10.1080/026990596124340</pub-id>
          <pub-id pub-id-type="pmid">8735663</pub-id>
        </element-citation>
      </ref>
      <ref id="b30-cpn-14-314">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deb</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lyons</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Koutzoukis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Rate of psychiatric illness 1 year after traumatic brain injury</article-title>
          <source>Am J Psychiatry</source>
          <year>1999</year>
          <volume>156</volume>
          <fpage>374</fpage>
          <lpage>378</lpage>
          <pub-id pub-id-type="pmid">10080551</pub-id>
        </element-citation>
      </ref>
      <ref id="b31-cpn-14-314">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schachar</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Dennis</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Mental health implications of traumatic brain injury (TBI) in children and youth</article-title>
          <source>J Can Acad Child Adolesc Psychiatry</source>
          <year>2015</year>
          <volume>24</volume>
          <fpage>100</fpage>
          <lpage>108</lpage>
          <!--<pub-id pub-id-type="pmcid">4558980</pub-id>-->
          <pub-id pub-id-type="pmid">26379721</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-cpn-14-314" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>(A) On the T2-weighted axial image, increased focal signal intensity in corpus callosum. (B) On the T1-weighted axial image, hemorrhage and contusion in right frontal lobe grey matter. (C) On the T1-weighted axial image, minimal intraventricular hemorrhage. (D) On the fluid-attenuated inversion recovery (FLAIR) examination axial image, contusion and related increase in focal signaling in the right frontal and left temporal lobes grey matter.</p>
      </caption>
      <graphic xlink:href="cpn-14-314f1"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
